Paliperidone palmitate (Invega Sustenna) is indicated for the treatment of schizophrenia and for the prevention of recurrence of symptoms of schizophrenia.
Paliperidone palmitate (Invega Sustenna) is indicated for the treatment of schizoaffective disorder as monotherapy and as an adjunct to mood stabilizers or antidepressants.